Similar articles for PMID: 12769790

Year	Number of Results
1996	2
1997	5
1998	4
1999	11
2000	3
2001	4
2002	8
2003	9
2004	5
2005	9
2006	16
2007	13
2008	8
2009	11
2010	16
2011	26
2012	29
2013	27
2014	37
2015	14
2016	19
2017	24
2018	19
2019	32
2020	35
2021	37
2022	22
2023	13
2024	0

1

Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.

Staudt MR, Dittmer DP. Staudt MR, et al. Curr Drug Targets Infect Disord. 2003 Jun;3(2):129-35. doi: 10.2174/1568005033481150. Curr Drug Targets Infect Disord. 2003. PMID: 12769790 Review.

2

Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.

Tso FY, West JT, Wood C. Tso FY, et al. J Virol. 2019 Mar 21;93(7):e02183-18. doi: 10.1128/JVI.02183-18. Print 2019 Apr 1. J Virol. 2019. PMID: 30651362 Free PMC article.

3

Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.

Garrigues HJ, Howard K, Barcy S, Ikoma M, Moses AV, Deutsch GH, Wu D, Ueda K, Rose TM. Garrigues HJ, et al. J Virol. 2017 Nov 30;91(24):e01532-17. doi: 10.1128/JVI.01532-17. Print 2017 Dec 15. J Virol. 2017. PMID: 28978712 Free PMC article.

4

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.

Gruffaz M, Zhou S, Vasan K, Rushing T, Michael QL, Lu C, Jung JU, Gao SJ. Gruffaz M, et al. mBio. 2018 May 8;9(3):e00756-18. doi: 10.1128/mBio.00756-18. mBio. 2018. PMID: 29739902 Free PMC article.

5

KSHV Genome Replication and Maintenance in Latency.

Ueda K. Ueda K. Adv Exp Med Biol. 2018;1045:299-320. doi: 10.1007/978-981-10-7230-7_14. Adv Exp Med Biol. 2018. PMID: 29896673 Review.

6

Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.

Gjyshi O, Roy A, Dutta S, Veettil MV, Dutta D, Chandran B. Gjyshi O, et al. J Virol. 2015 Aug;89(15):7874-92. doi: 10.1128/JVI.00895-15. Epub 2015 May 20. J Virol. 2015. PMID: 25995248 Free PMC article.

7

Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.

Lu J, Jha HC, Verma SC, Sun Z, Banerjee S, Dzeng R, Robertson ES. Lu J, et al. J Virol. 2014 Apr;88(8):4204-17. doi: 10.1128/JVI.03855-13. Epub 2014 Jan 29. J Virol. 2014. PMID: 24478433 Free PMC article.

8

Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.

Wakeman BS, Izumiya Y, Speck SH. Wakeman BS, et al. J Virol. 2016 Dec 16;91(1):e01434-16. doi: 10.1128/JVI.01434-16. Print 2017 Jan 1. J Virol. 2016. PMID: 27795414 Free PMC article.

9

Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.

Chang PJ, Chen LW, Chen LY, Hung CH, Shih YJ, Wang SS. Chang PJ, et al. J Virol. 2017 Sep 12;91(19):e00505-17. doi: 10.1128/JVI.00505-17. Print 2017 Oct 1. J Virol. 2017. PMID: 28701396 Free PMC article.

10

Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.

Sanchez EL, Pulliam TH, Dimaio TA, Thalhofer AB, Delgado T, Lagunoff M. Sanchez EL, et al. J Virol. 2017 Apr 28;91(10):e02237-16. doi: 10.1128/JVI.02237-16. Print 2017 May 15. J Virol. 2017. PMID: 28275189 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

418 results

Results by year